Refreshments in Active Ingredients
Valsartan: regenerative pressure
The blood vicar Valsartan is again in criticism – again, the drug of a manufacturer has been recovered, found to be property. Which parties are involved and what patients should be aware now.
The previous reminder since July 2018 was not enough. Now again a drug drug from a drugstore was recorded. It's about once again Valsartan recallBut this time comes the drug from another manufacturer. Little Mylan Laboratories Limited will affect this time – the medicine of this manufacturer can not be made until the fourth update for the production of medicines with falshart.
Valsartan thinks: These parties are influenced
Valsartan is a hypotension used in a variety of high blood pressure medicines. It is made by various manufacturers worldwide. The compounds are now found in some labile labels by Mylan Laboratories Limited of India.
It is N-nitrosodiethylamine (NDEA), a substance that causes cancer. The fabric can form in the production of Valsartan, if not enough work is sufficient.
In a statement, the company calls the related products and parties:
- Valsartan dura: 40 mg, 80 mg, 160 mg and 320 mg; 28, 56 and 98 film cassettes; PZN 09239582, 09239599, 09239607, 09239613, 09239636, 09333803 and 09333826
- Valsartan / HCT (Valsartan, Hydrochlorothiazide) Mylan: 80 mg / 12.5 mg, 160 mg / 12.5 mg, 160 mg / 25 mg, 320 mg / 12.5 mg, 320 mg / 25 mg; 6 and 98 film cassettes; PZN 10054959, 10054965, 10054971, 10054988, 10054994, 10055002, 10055019, 10055025, 10055031 and 10055048
Which patients should now have: Do not just end therapy!
important: Everyone who has detected these medicines and the various followers of the indicated PZN (central pharmaceuticals) must never stop the therapy!
Talk to your doctor. The cancer risk, according to the announcement of the company, is not increased by the risk that occurs when the blood pressure medication is stopped. About the effects of untreated hypertensia are more directors.
Already in many respects expected sartans
The notion of hypertensive drug is not the first. It was not until the beginning of July that Valsartan's differences were incorporated by invalids, and the number of messages is slowly present. At that time, the counterfeit drugs of Chinese manufacturer Zhejiang Huahai Pharmaceuticals, here carcinogenic substances were found. In September, there was a report that even anti-hypertensives of Indian manufacturer Hetero Labs were contaminated and thus recovered.
In addition, divisions of the drug Irbesartan Heumann 300 mg have now been recorded, as reported by the German Hypertension League.
Despite any references and possible cancer risk: Do not stop simply medicines!
Sartans are among the agents that are used for high blood pressure and heart failure and help with cardiovascular disease. Even after heart attacks, the preparations are often used.
Sartans are not just in criticism. In short, a study found that blood pressure medication with ACE inhibitors can cause choking. Cardiologists are skeptical.
However, as with the contaminated sartans, the blood pressure reduction of medicines should never be recorded, consultation with a physician or pharmacist is absolutely necessary. At the risk of being detached from non-demanding stops, according to the German Hypertension League is much higher than the potential, outgoing cancer risk. Doctor advised if you are a risk group and identify with you as a substitute drug replacement.
Here's a list of all listed Sartan medicines including PZN. In addition, drugs of Novartis and TAD Pharma as Aurobindo should not be affected. The German Apotheker, however, confirmed that in certain cases, certain packets should no longer be found. Check your app, you do not have to be sure!